secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001798749-24-000055
Event type: regulatory
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate regains Nasdaq audit committee compliance by appointing Habib J. Dable
-------------------------------------------------------------------------------

- Company notified Nasdaq of noncompliance on Oct 11 due to only two audit committee members after Dr. Katabi's resignation.
- Board appointed director Habib J. Dable to the audit committee effective Oct 17, 2024.
- With Dable's appointment, Aerovate regained compliance with Nasdaq Listing Rule 5605(c)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/0001798749-24-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/tmb-20241011x8k.htm
  HTML page:      https://secwatch.observer/filing/0001798749-24-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer